Back to the main directory
Press Release
- Déclaration hebdomadaire des transactions sur CCI 2023 09 18 - 2023 09 22 by GlobeNewsWire
- Standard Lithium Strengthens C-Suite: Salah Gamoudi Appointed CFO, Kara Norman Steps Into New Role as CAO by GlobeNewsWire
- Enovis to Acquire LimaCorporate S.p.A. by GlobeNewsWire
- Concentrix and Webhelp Complete Combination, Creating a Diversified Global CX Leader, Well-Positioned for Growth by GlobeNewsWire
- SKEL fjárfestingafélag hf.: Endurkaup vika 38 by GlobeNewsWire
- Global Blue Introduces Financial Guidance and Long-term Targets by BusinessWire
- Ault Alliance Announces Strategic Corporate Alignment by BusinessWire
- Kvika banki hf.: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun by GlobeNewsWire
- Brunswick Corporation Named by Newsweek as One of the World’s Most Trustworthy Companies by GlobeNewsWire
- Fluor Announces Full Mandatory Conversion of Series A 6.50% Cumulative Perpetual Convertible Preferred Stock by BusinessWire
- KKR Announces Intra-Quarter Monetization Activity Update for the Third Quarter by BusinessWire
- Castle Biosciences, Leading Skin Cancer Expert, Darrell Rigel, M.D., M.S., and IMPACT Melanoma Board Member to Ring Nasdaq Closing Bell on Sept. 27, 2023, to Raise Awareness of Melanoma by BusinessWire
- Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference by GlobeNewsWire
- Sprott Private Resource Lending Fund III Completes Final Closing by GlobeNewsWire
- Theratechnologies soumet un supplément à la licence de produit biologique (sBLA) pour la formulation F8 de la tésamoréline aux fins d’examen par la FDA by GlobeNewsWire
- Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference by GlobeNewsWire
- Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human by GlobeNewsWire
- Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients by GlobeNewsWire
- Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s) by EQS Group AG
- Phillips Edison & Company Announces Appointment of Anthony “Tony” Terry to Board of Directors by GlobeNewsWire
- LifeVantage Files Definitive Proxy Statement by GlobeNewsWire
- Theratechnologies annonce une entente de principe avec Marathon afin de modifier certaines des modalités et conditions de sa facilité de prêt by GlobeNewsWire
- Genmab Announces European Commission Approval of TEPKINLY® (epcoritamab) for Adults with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) by GlobeNewsWire
- Enento Group’s financial information 2024 by GlobeNewsWire
- Sampo plc: Managers’ Transactions (Alsaker) by GlobeNewsWire